when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

DAIICHI SANKYO · news · pharmadog

← back to DAIICHI SANKYO

News mentioning DAIICHI SANKYO

22 stories

10dRevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 winendpoints

15dContext scraps bispecific T-cell engager program to extend cash runway deeper into 2027fiercebiotech

17d‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal everbiospace

21dDaiichi’s pipeline falls behind rivals as cash flow nears peak: analystsbiospace

22dMerck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combinationfiercebiotech

23dEli Lilly tops new biopharma ranking on launch success, development speedfiercebiotech

23dGSK partner Hansoh reports another phase 3 win for priority ADCfiercebiotech

25dAstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidatesfiercebiotech

Jul 21, 26‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx dealfiercebiotech

Jul 15, 26Merck ADC, in China study, shows potential to replace chemo in lung cancerbiopharma dive

Jul 8, 26STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

Jul 6, 26Novartis to acquire ADC developer in a deal worth up to $1.5Bbiopharma dive

Jun 26, 26On second try, Acadia drug gets nod from European regulatorsbiopharma dive

Jun 4, 26A Spanish biotech banks $87M to make differentiated ADCsbiopharma dive

May 29, 26At ASCO, Merck makes case for a ‘cornerstone’ cancer drugbiopharma dive

May 18, 26Merck ADC, licensed from China, hits mark in first big global trialbiopharma dive

May 11, 26Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise pushendpoints

May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive

May 8, 26Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive

May 8, 26Daiichi Sankyo posts 'extraordinary loss' of nearly $1Bendpoints

May 5, 26Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congressonclive

Apr 24, 26Daiichi Sankyo postpones annual results, stock dipsendpoints